Gentamicin Sulfate Injection, Solution
Product Images NDC 51662-1597

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gentamicin Sulfate (NDC 51662-1597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch (51662 1597 2 Pouch Label)

Label for Gentamicin Sulfate Injection, USP 80 mg/2 mL (40 mg/mL) in a 2 mL vial. The label includes NDC 51662-1597-2, lot number, expiration date, and instructions indicating use for intravenous or intramuscular administration. The product is manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The label specifies the need for dilution before intravenous use and lists key ingredients and preservatives.*

FDA Label Image

Case (51662 1597 3 Case Label)

Label for GENTAMICIN SULFATE Injection, USP 80 mg/2 mL (40 mg/mL) in a 2 mL vial, packaged as a case of 25. The label includes the NDC 51662-1597-3, lot number, expiration date, and detailed usage and storage instructions. Manufactured by HF Acquisition Co, LLC.*

FDA Label Image

Serialized Rfid Label (51662 1597 3 Serialized Rfid Label)

GENTAMICIN SULFATE injection solution label shows a barcode with numeric codes and instructions to see the manufacturer's package insert. Label includes the labeler name HF Acquisition Co LLC, DBA HealthFirst, and indicates the product is prescription only (RX ONLY).*

FDA Label Image

Boxed Warning (Boxed)

A warnings text panel for Gentamicin Sulfate Injection, 40 mg/mL, emphasizing the need for close clinical observation due to potential nephrotoxicity, neurotoxicity, and ototoxicity. It advises monitoring renal and cranial nerve function, serum concentrations, and cautions about concurrent use with other neurotoxic or ototoxic drugs and diuretics. It also notes potential fetal harm when administered during pregnancy.*

FDA Label Image

Dosage 2 (Dosage 2)

A dosage adjustment guide table for patients with renal impairment, indicating adjustments based on serum creatinine levels, approximate creatinine clearance rates, and corresponding percent of usual doses to administer at eight-hour intervals after the initial dose.*

FDA Label Image

Dosage 1 (Dosage)

A dosage schedule guide table for Gentamicin Sulfate injection solution 40 mg/mL for adults with normal renal function. It lists patient weight in kilograms and pounds, and corresponding usual doses for serious infections as well as doses for life-threatening infections, both at eight-hour intervals. Dosages are provided in mg and mL per dose.*

FDA Label Image

Structure (Structure)

Chemical structure of gentamicin sulfate, showing the molecular arrangement with labeled R groups corresponding to C1, C2, and C1A variants. The structure includes multiple rings with amino and hydroxyl groups, representing the components of gentamicin associated with sulfate ions.*

FDA Label Image

Vial Label (Vial Lable)

Label of Gentamicin Sulfate Injection, USP 80 mg/2 mL (40 mg/mL as Gentamicin) in a 2 mL single-dose vial. Intended for intravenous or intramuscular use with a note that it must be diluted for intravenous use. Distributed by Hospira, Inc., Lake Forest, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.